期刊论文详细信息
Journal of Nanobiotechnology
Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis
Liangcong Hu1  Ranyang Tao1  Bobin Mi1  Hang Xue1  Ze Lin1  Lang Chen1  Yiqiang Hu1  Xudong Xie1  Yuan Xiong1  Chenchen Yan1  Guohui Liu1  Adriana C. Panayi2 
[1] Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology;Department of Plastic Surgery, Brigham and Women’s Hospital, Harvard Medical School;
关键词: Exosomes;    Mesenchymal stem cells;    Pioglitazone;    Diabetic wound;    Angiogenesis;   
DOI  :  10.1186/s12951-021-00894-5
来源: DOAJ
【 摘 要 】

Abstract Background Enhanced angiogenesis can promote diabetic wound healing. Mesenchymal stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising candidates for the treatment of diabetic wound healing. The present study aimed to investigate the effect of exosomes derived from MSCs pretreated with pioglitazone (PGZ-Exos) on diabetic wound healing. Results We isolated PGZ-Exos from the supernatants of pioglitazone-treated BMSCs and found that PGZ-Exos significantly promote the cell viability and proliferation of Human Umbilical Vein Vascular Endothelial Cells (HUVECs) injured by high glucose (HG). PGZ-Exos enhanced the biological functions of HUVECs, including migration, tube formation, wound repair and VEGF expression in vitro. In addition, PGZ-Exos promoted the protein expression of p-AKT, p-PI3K and p-eNOS and suppressed that of PTEN. LY294002 inhibited the biological function of HUVECs through inhibition of the PI3K/AKT/eNOS pathway. In vivo modeling in diabetic rat wounds showed that pioglitazone pretreatment enhanced the therapeutic efficacy of MSCs-derived exosomes and accelerated diabetic wound healing via enhanced angiogenesis. In addition, PGZ-Exos promoted collagen deposition, ECM remodeling and VEGF and CD31 expression, indicating adequate angiogenesis in diabetic wound healing. Conclusions PGZ-Exos accelerated diabetic wound healing by promoting the angiogenic function of HUVECs through activation of the PI3K/AKT/eNOS pathway. This offers a promising novel cell-free therapy for treating diabetic wound healing. Graphic abstract

【 授权许可】

Unknown   

  文献评价指标  
  下载次数:0次 浏览次数:0次